The International Cancer Genome Consortium (ICGC) announced plans to launch the ICGC for Medicine (ICGCmed), a new phase of the consortium that will link genomics to clinical information and health. The collaborative project will build upon the vast database of genomic discoveries of the ICGC, which, since its launch in 2007, has been mapping 25,000 different cancer genomes in 50 different tumor types and making this data freely available to qualified researchers around the world.
By linking the ICGC data with clinical information, ICGCmed aims to accelerate the movement of this information into the clinic to guide prevention, early detection, diagnosis and prognosis, and provide the information needed to match patients’ disease to the most effective combinations of therapy. ICGCmed research will apply to a broad spectrum of cancers, from early cancers through to metastases.
Source: UC Davis Health System press release, April 17, 2016.